Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

We recently compiled a list titled Buffett Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we will look at ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

Support for people living with obesity is “insufficient”, experts have said after a new report revealed that some patients are being asked to wait for up to five years for specialist support. Some ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss ...